← Back to Search

Lifestyle Physical Activity for Multiple Sclerosis

N/A

Waitlist Available

Led By Lara Pilutti, PhD

Research Sponsored by University of Ottawa

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 6-months and 12-months

Awards & highlights

Study Summary

This trial will examine whether a 6-month lifestyle physical activity intervention can improve cardiorespiratory fitness and reduce vascular comorbidity risk in people with multiple sclerosis.

Eligible Conditions

Multiple Sclerosis

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 6-months and 12-months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 6-months and 12-months

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 6-months and 12-months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Cardiorespiratory Fitness

Secondary outcome measures

Blood Glucose

Change in Blood Pressure

Change in Body Composition

+2 more

Other outcome measures

Change in Body Circumferences

Change in Optical Coherence Tomography (OCT) measures

Change in Physical Activity - assessed by Godin Leisure-Time Exercise Questionnaire

+3 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Lifestyle Physical ActivityExperimental Treatment1 Intervention

The primary content of the website will be delivered through interactive video courses. The courses will be released seven times during the first two months, four times during the second two months, and twice during the final two months of the intervention. The website Tracker feature will allow for tracking of daily step counts as well as setting goals and monitoring progress. The one-on-one video chats will be conducted face to face through Zoom and will be semi-scripted. The chats will consist of an ongoing review of goal-setting and progress toward goal attainment through Tracker as well as discussion of strategies and facilitators of behavioral changes based on social cognitive theory and current website content. The chats will occur at the same frequency as the video course release. For the second 6 months of the study, participants will be asked to maintain their usual activities.

Group II: General WellnessActive Control1 Intervention

The general wellness condition will focus on self-managing MS through means other than physical activity. The materials are transformations of brochures provided by the National Multiple Sclerosis Society. The delivery of the Internet materials and chat sessions will occur on the same schedule and frequency as the intervention condition, and will have a comparable time commitment. This condition will account for attention and social contact as well as other possible biases such as initial reactivity and time spent on the website and video chats. For the second 6 months of the study, participants will be asked to maintain their usual activities.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Lifestyle Physical Activity

2018

N/A

~40

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of OttawaLead Sponsor

205 Previous Clinical Trials

266,086 Total Patients Enrolled

5 Trials studying Multiple Sclerosis

327 Patients Enrolled for Multiple Sclerosis

University of Illinois at ChicagoOTHER

607 Previous Clinical Trials

1,559,350 Total Patients Enrolled

13 Trials studying Multiple Sclerosis

1,701 Patients Enrolled for Multiple Sclerosis

National Multiple Sclerosis SocietyOTHER

95 Previous Clinical Trials

9,478 Total Patients Enrolled

93 Trials studying Multiple Sclerosis

9,124 Patients Enrolled for Multiple Sclerosis

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants can join this medical trial?

"Affirmative. According to data furnished on clinicaltrials.gov, this research project is actively looking for enrollees and has been since July 21st 2019. The study needs around 48 individuals from a single site and was most recently updated on November 23rd 2022."

Answered by AI

Are participants being accepted for this trial at present?

"This clinical trial, which was made available on July 21st 2019, is still recruiting participants and the listing was last updated November 23rd 2022 according to findings reported on clinicaltrials.gov."

Answered by AI

Could I potentially register for this clinical trial?

"This investigation is recruiting 48 individuals diagnosed with Multiple sclerosis, aged between 18 and 65. The inclusion criteria also mandates that these people have a score of less than 6 on the Expanded Disability Status Scale (EDSS), must be free from relapse for at least 30 days, demonstrate stable condition regulation by medication over the past half year, possess internet capabilities, are not severely ill due to cardiovascular disease based on Framingham Cardiovascular Disease Risk Score calculator assessments as well as Get Active Questionnaire results and American Heart Association/American College of Sports Medicine Health/Fitness Facility Pre-participation Screening Questionnaire health history section. Moreover, they"

Answered by AI